University Cologne, Faculty of Medicine and University Hospital Cologne, Department of Diagnostic and Interventional Radiology, Cologne, Germany.
Fraunhofer Institute of Optronics, System Technologies and Image Exploitation IOSB, Karlsruhe, Germany.
Front Endocrinol (Lausanne). 2023 May 19;14:1098898. doi: 10.3389/fendo.2023.1098898. eCollection 2023.
The bone marrow's iodine uptake in dual-energy CT (DECT) is elevated in malignant disease. We aimed to investigate the physiological range of bone marrow iodine uptake after intravenous contrast application, and examine its dependence on vBMD, iodine blood pool, patient age, and sex.
Retrospective analysis of oncological patients without evidence of metastatic disease. DECT examinations were performed on a spectral detector CT scanner in portal venous contrast phase. The thoracic and lumbar spine were segmented by a pre-trained neural network, obtaining volumetric iodine concentration data [mg/ml]. vBMD was assessed using a phantomless, CE-certified software [mg/cm3]. The iodine blood pool was estimated by ROI-based measurements in the great abdominal vessels. A multivariate regression model was fit with the dependent variable "median bone marrow iodine uptake". Standardized regression coefficients (β) were calculated to assess the impact of each covariate.
678 consecutive DECT exams of 189 individuals (93 female, age 61.4 ± 16.0 years) were evaluated. AI-based segmentation provided volumetric data of 97.9% of the included vertebrae (n=11,286). The 95 percentile of bone marrow iodine uptake, as a surrogate for the upper margin of the physiological distribution, ranged between 4.7-6.4 mg/ml. vBMD (p <0.001, mean β=0.50) and portal vein iodine blood pool (p <0.001, mean β=0.43) mediated the strongest impact. Based thereon, adjusted reference values were calculated.
The bone marrow iodine uptake demonstrates a distinct profile depending on vBMD, iodine blood pool, patient age, and sex. This study is the first to provide the adjusted reference values.
在双能 CT(DECT)中,骨髓的碘摄取在恶性疾病中升高。我们旨在研究静脉注射对比剂后骨髓碘摄取的生理范围,并检查其对 vBMD、碘血池、患者年龄和性别依赖性。
对无转移性疾病证据的肿瘤患者进行回顾性分析。在光谱探测器 CT 扫描仪上进行门静脉对比期的 DECT 检查。使用预先训练的神经网络对胸腰椎进行分段,获得体积碘浓度数据[mg/ml]。使用无仿射体、CE 认证软件评估 vBMD[mg/cm3]。通过大腹部血管的 ROI 测量估计碘血池。使用多元回归模型拟合因变量“中位数骨髓碘摄取”。计算标准化回归系数(β)以评估每个协变量的影响。
对 189 名个体的 678 次连续 DECT 检查(93 名女性,年龄 61.4±16.0 岁)进行了评估。基于 AI 的分段提供了 97.9%(n=11286)包含椎体的体积数据。骨髓碘摄取的第 95 百分位数作为生理分布上限的替代值,范围在 4.7-6.4mg/ml 之间。vBMD(p<0.001,平均β=0.50)和门静脉碘血池(p<0.001,平均β=0.43)的影响最大。基于此,计算了调整后的参考值。
骨髓碘摄取表现出明显的特征,取决于 vBMD、碘血池、患者年龄和性别。本研究首次提供了调整后的参考值。